Literature DB >> 28509225

A case of membranoproliferative glomerulonephritis developed over twenty years with three different findings of renal pathology.

Yoshikatsu Kaneko1, Kazuhiro Yoshita2, Hideyuki Kabasawa3, Naofumi Imai2, Yumi Ito2, Mitsuhiro Ueno4, Shinichi Nishi5, Ichiei Narita2.   

Abstract

A 31-year-old woman with proteinuria, hypocomplementemia, rheumatoid factor, and high serum polyclonal IgM concentration was admitted to our hospital for renal biopsy. She had a past history of two renal biopsies. When she was 12 years old, she developed proteinuria, microscopic hematuria, and hypocomplementemia. She was diagnosed as having 'IgM nephropathy' based on minor glomerular abnormalities as determined by light microscopy and IgM and C3 deposition in the mesangial region by immunofluorescence microscopy at the first biopsy. Despite corticosteroid treatment, her proteinuria did not improve and she discontinued regular outpatient checkups. When she was 29 years old and pregnant, she developed preeclampsia and, after delivery, a second renal biopsy was implemented. She was diagnosed as having progressed 'IgM nephropathy' with endotheliosis induced by preeclampsia. She was treated with angiotensin II receptor blocker and her proteinuria diminished; however, 1 year after the delivery, she developed proteinuria again, along with microscopic hematuria and hypocomplementemia. A third renal biopsy was conducted at 31 years of age and she was diagnosed as having membranoproliferative glomerulonephritis (MPGN) type I on the basis of diffuse mesangial proliferation, endocapillary hypercellularity with double contour of the capillary wall, and lobular formation in glomeruli, as determined by light microscopy. Immunofluorescence staining demonstrated deposits of C3, C4, C1q, and IgM in the mesangial region and capillary wall. She underwent corticosteroid therapy followed by normalization of urinalysis and serum complement level. Although she had initially been diagnosed with 'IgM nephropathy', she was finally diagnosed with secondary MPGN and was successfully treated by corticosteroid therapy.

Entities:  

Keywords:  Foam cell; IgM nephropathy; Preeclampsia; Rheumatoid factor; Secondary MPGN

Year:  2012        PMID: 28509225      PMCID: PMC5413730          DOI: 10.1007/s13730-012-0042-1

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  18 in total

1.  IgM-associated primary diffuse mesangial proliferative glomerulonephritis: natural history and prognostic indicators.

Authors:  D J O'Donoghue; W Lawler; L P Hunt; E J Acheson; N P Mallick
Journal:  Q J Med       Date:  1991-04

Review 2.  Distinguishing minimal-change disease from mesangial disorders.

Authors:  W A Border
Journal:  Kidney Int       Date:  1988-09       Impact factor: 10.612

3.  Secondary membranoproliferative glomerulonephritis.

Authors:  H G Rennke
Journal:  Kidney Int       Date:  1995-02       Impact factor: 10.612

4.  Antiglobulins and glomerulonephritis. Classification of patients by the reactivity of their sera and renal tissue with aggregated and native human IgG.

Authors:  R D Rossen; M A Reisberg; J T Sharp; W N Sucki; F X Schloeder; L L Hill; G Eknoyan
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

5.  Rheumatoid factors and glomerulonephritis.

Authors:  M Miyazaki; M Endoh; T Suga; N Yano; T Kuramoto; Y Matsumoto; K Eguchi; M Yagame; M Miura; Y Nomoto
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

6.  Presence of foam cells in kidney interstitium is associated with progression of renal injury in patients with glomerular diseases.

Authors:  Yan Wu; Yan Chen; Dan Chen; Caihong Zeng; Leishi Li; Zhihong Liu
Journal:  Nephron Clin Pract       Date:  2009-08-12

Review 7.  Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis.

Authors:  J S Cameron; D R Turner; J Heaton; D G Williams; C S Ogg; C Chantler; G B Haycock; J Hicks
Journal:  Am J Med       Date:  1983-02       Impact factor: 4.965

8.  IgG, IgA and IgM rheumatoid factors in patients with glomerulonephritis.

Authors:  M Endoh; T Suga; H Sakai
Journal:  Nephron       Date:  1985       Impact factor: 2.847

Review 9.  Membranoproliferative glomerulonephritis.

Authors:  Bassam Alchi; David Jayne
Journal:  Pediatr Nephrol       Date:  2009-11-12       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.